BioExx Announces Election of Directors

TORONTO, ONTARIO -- (Marketwired) -- 06/26/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:…

Continue Reading

BioExx Receives Notices of Allowance for Two U.S. Protein Patent Applications

TORONTO, ONTARIO -- (Marketwired) -- 06/18/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:…

Continue Reading

BioExx Announces Q1 2013 Results

Conference Call: Thursday, May 16, 9:00 a.m. ET Updated Dial-in Numbers: 416-340-8061 / 866-225-0198 / 800-6578-9898

Continue Reading

Notice of Q1 2013 Results Conference Call

TORONTO, ONTARIO -- (Marketwired) -- 05/07/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:…

Continue Reading

BioExx Announces Adoption of Advanced Notice By-Law

TORONTO, ONTARIO -- (Marketwired) -- 05/06/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:…

Continue Reading

BioExx Provides Update on Strategic Partner Process

TORONTO, ONTARIO -- (Marketwired) -- 04/30/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:…

Continue Reading

REPEAT: BioExx Provides Update on Strategic Partner Process

TORONTO, ONTARIO -- (Marketwired) -- 04/02/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:…

Continue Reading

REPEAT: BioExx Announces 2012 Annual and Q4 Results

Conference Call: Tuesday, April 2, 8:30 a.m. ET Updated Dial-in Numbers: 416-340-8061 / 866-225-0198 / 800-6578-9898

Continue Reading

BioExx Announces 2012 Annual and Q4 Results

Conference Call: Tuesday, April 2, 8:30 a.m. ET Updated Dial-in Numbers: 416-340-8061 / 866-225-0198 / 800-6578-9898

Continue Reading

BioExx Provides Update on Strategic Partner Process

TORONTO, ONTARIO -- (Marketwire) -- 04/01/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:…

Continue Reading